The scientists of the German Center for Infection Research (DZIF) contribute their insights and professional expertise to the debate within society, thus supporting important decision-making processes
Researchers at Karolinska Institutet, Umeå University, and DZIF scientists at the University of Bonn have identified a new group of molecules that have an antibacterial effect against many antibiotic
Please use this image only in connection with this press release.
Approximately two-thirds of the population in Germany have been fully vaccinated against the corona virus to date. But the immune protection from the vaccine diminishes over time. A booster
Bitte verwenden Sie dieses Bild nur im Zusammenhang mit dieser Pressemitteilung.
While the highly infectious SARS-CoV-2 Delta variant has already become predominant in Germany and in most European nations, little was known about its spread in Africa. German Center for Infection
Ahead of the “World Antimicrobial Awareness Week” (November 18-24) 20 national and international organizations from academia, healthcare, global health and the pharmaceutical industry appealed today
Please use the image only in connection with this press release.
SARS-CoV-2 affects not only lungs and airways, but influences many organs of the human body. How it damages small blood vessels in the brain was deciphered by a consortium of the German Centers for
The right therapy for the right patient group at the right time - that is what precision medicine makes possible. In the current issue of the DZG magazine SYNERGIE, the German Centers for Health
The German Center for Infection Research (DZIF) and the Helmholtz Centre for Infection Research (HZI) have developed a concept to form a National Alliance for Pandemic Therapeutics (NA-PATH). They
The intestine of a healthy person contains hundreds of different bacteria that provide efficient protection against infections. However, if the equilibrium of this community, known as the microbiota
The DZIF Academy is pleased to open the call for applications for two prizes in 2021: the DZIF Prize for Fundamental Translational Infection Research and the DZIF Prize for Clinical Translational